mond aandoeningen dysgeusia taste changes
Conditions
Interventions
Patients will be blinded to receive either PBMT or sham-PBMT.
Sponsors
Amsterdam UMC
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with multiple myeloma; 18 years of age receiving HDM followed by SCT
Exclusion criteria
Exclusion criteria: Having taste disorders not related to SCT (e.g. COVID-19) History of a head and neck tumor treated with surgery and/or (chemo)radiation Neurological diseases (e.g. Parkinson*s disease)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective taste function | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective taste function Presence and severity of hyposalivation Presence and severity of xerostomia Patient reported oral mucositis Global and oral health-related QoL Patient reported oral health Caloric/dietary intake | — |
Countries
Netherlands
Outcome results
None listed